Search
- Oct 8, 2023
Rockefeller Neuroscience Institute’s Marc Haut discusses Alzheimer’s advances at #HLTH2023
Dr. Haut talks about demand he is seeing for Leqembi, what it means for the Alzheimer’s field, and opening the blood-brain-barrier.
Also look for unique social pages for BiotechTV U.
#1. Ultragenyx's Emil Kakkis on Angelman syndrome data, rare disease treatment modalities, and more
#2. The CEO of Madrigal on the launch of Rezdiffra for NASH liver disease
#3. Sutro Biopharma's CEO on ADCs, non-cell protein synthesis, and more
#4. Verve Therapeutics' CEO on today's gene editing clinical trial pause
#5. Daphne Zohar on becoming the CEO of Seaport Therapeutics and a $100M series A